The Hospital-at-Home (HaH) model has revolutionized patient care by allowing individuals to receive hospital-level treatment in the comfort of their own homes. This alternative to traditional hospital stays has been a game-changer for patients like Dr. Jared Conley’s elderly patient, who typically benefits from HaH for heart failure exacerbations. However, when the waiver funding the program expired on September 30, 2025, hospitals and patients were left grappling with a less efficient system.
Dr. Conley, an Assistant Professor at Harvard Medical School and co-chair of the US-based Hospital at Home Tech Council, emphasizes the importance of the HaH model. Patients often express their desire to return home, where they can experience a healing environment with improved sleep and a sense of autonomy. Beyond patient comfort, HaH also helps reduce inpatient census and alleviate bottlenecks in emergency departments, highlighting its system-wide value.
The development of Hospital at Home has been a long time coming, with pioneers like Dr. Bruce Leff laying the foundation for this innovative approach to care. Despite initial challenges with funding, research consistently demonstrated the model’s benefits, leading to its gradual adoption. The COVID-19 pandemic further accelerated the implementation of HaH, with CMS issuing a waiver that allowed hospitals to be reimbursed for providing care at home.
Dr. Conley’s personal experience with HaH following a foot injury underscored the benefits of receiving care in a familiar environment. While the clinical care was effective during his brief inpatient stay, the hospital setting posed challenges like overnight alarms and lack of privacy. Transitioning home allowed him to continue treatment with intravenous antibiotics in a more comfortable and supportive environment.
Scaling the HaH model poses challenges, particularly concerning payment and legislation uncertainties. Dr. Conley emphasizes the demographic imperative, noting that the aging population will require more hospital beds than currently available. HaH offers a viable solution by reallocating resources to provide hospital-level care safely at home, freeing up inpatient beds for those in critical need.
The future of Hospital at Home lies in advanced monitoring and integrated technology to ensure patient safety. Dr. Conley collaborates with various stakeholders to develop technologies that enhance patient care and minimize risks associated with home treatment. While the recent reinstatement of HaH funding is a step in the right direction, long-term authorization is crucial to sustain a model that prioritizes patient-centered care and efficiency.
In conclusion, Hospital at Home has proven to be a successful and patient-friendly alternative to traditional hospital stays. With ongoing advancements in technology and a growing body of evidence supporting its effectiveness, HaH is poised to become a standard practice in healthcare delivery. Dr. Conley’s advocacy for permanent authorization of the HaH model underscores its importance in providing high-quality care to patients in a familiar and supportive environment.
